Abound Wealth Management
AZR icon

Abound Wealth Management’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Abound Wealth Management’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5 Hold
1
– – ﹤0.01% 1440
2026
Q2 		$3 Hold
1
– – ﹤0.01% 1356
2026
Q1 		$2 Hold
1
– – ﹤0.01% 1487
2025
Q4 		$6 Hold
1
– – ﹤0.01% 1429
2025
Q3 		$10 Hold
1
– – ﹤0.01% 1354
2025
Q2 		$9 Hold
1
– – ﹤0.01% 1296
2025
Q1 		$18 Hold
1
– – ﹤0.01% 1264
2024
Q4 		$28 Hold
1
– – ﹤0.01% 1220
2024
Q3 		$27 Hold
1
– – ﹤0.01% 1296
2024
Q2 		$32 Hold
1
– – ﹤0.01% 1160
2024
Q1 		$36 Hold
1
– – ﹤0.01% 1287
2023
Q4 		$51 Hold
1
– – ﹤0.01% 1305
2023
Q3 		$76 Buy
+1
New +$118 ﹤0.01% 1153

Other funds holding AZR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Manchester Capital Management
Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Abound Wealth Management's AZR Position: Q3 2026 in Review

Abound Wealth Management held its Azora Therapeutics, Inc. Common Stock (AZR) position steady in Q3 2026 at 1 share worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #1440.

Abound Wealth Management first reported a position in AZR in Q3 2023 and has held it in 13 quarters since. The position peaked at $76 in Q3 2023. 7 funds tracked by Wall St. Rank hold AZR as of Q3 2026.

  • Abound Wealth Management held 1 share of Azora Therapeutics, Inc. Common Stock worth $5 as of Q3 2026.
  • Abound Wealth Management left its Azora Therapeutics, Inc. Common Stock share count unchanged in Q3 2026.
  • Azora Therapeutics, Inc. Common Stock made up ﹤0.01% of Abound Wealth Management's portfolio in Q3 2026, its #1440 holding.
  • Abound Wealth Management first reported a position in Azora Therapeutics, Inc. Common Stock in Q3 2023 and has held it in 13 quarters since.
  • Abound Wealth Management's Azora Therapeutics, Inc. Common Stock position peaked at $76 in Q3 2023.
  • 7 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q3 2026.

Based on Abound Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.